India New Issue-Mankind Pharma accepts bids for bond issue, bankers say

Mankind Pharma

15/10/2024 09:05

MUMBAI, Oct 15 (Reuters) - India's Mankind Pharma  MNKI.NS  has accepted bids worth an
aggregate of 50 billion rupees ($594.9 million) for bonds maturing in 18 months, two years and
three years and one month, three bankers said on Wednesday.
    It will pay a coupon of 7.99% each on the shorter duration papers and 7.97% on the above
three-year bonds. The coupon would be payable on a semi-annual basis.
    It had invited bids from bankers and investors for the issue earlier in the day, the bankers
said.
    
 
   Here is the list of deals reported so far on Oct 15: 
                                                                          
 Issuer         Tenure        Coupon (in %)  Issue size (in  Bidding      Rating
                                             bln rupees)*    date         
                                                                          
 Mankind        18 months     7.99           12.50           Oct. 15      AA+ (Crisil,
 Pharma                       (semi-annual)                               ICRA)
 Mankind        2 years       7.99           12.50           Oct. 15      AA+ (Crisil,
 Pharma                       (semi-annual)                               ICRA)
 Mankind        3 years and   7.97           25              Oct. 15      AA+ (Crisil,
 Pharma         1 month       (semi-annual)                               ICRA)
 Bajaj Housing       5 years  To be decided            10+5  Oct. 16      AAA (Crisil)
 Finance                                                                  
 
*Size includes base plus greenshoe for some issues

($1 = 84.0420 Indian rupees)

 (Reporting by Dharamraj Dhutia and Bhakti Tambe
Editing by Sumana Nandy)
 ((Dharamraj.dhutia@tr.com))